A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum. (Q40244179)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

18 March 2020

title

A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

experimental infection

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

18 March 2020

author name string

S Farajnia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

18 March 2020

publication date

1 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

18 March 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

18 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

15-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

Leishmaniasis worldwide and global estimates of its incidence

18 March 2020

cites work

1 reference

Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis

21 January 2018

1 reference

Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran

21 January 2018

1 reference

Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.

21 January 2018

1 reference

Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis

21 January 2018

1 reference

Leishmania specific CD4 T cells release IFNγ that limits parasite replication in patients with visceral leishmaniasis

21 January 2018

1 reference

CD8 T cell exhaustion in human visceral leishmaniasis

21 January 2018

1 reference

Regulation of immunity during visceral Leishmania infection

21 January 2018

1 reference

Vaccines to prevent leishmaniasis

21 January 2018

1 reference

Leishmaniasis Vaccine: Where are We Today?

21 January 2018

1 reference

Vaccines for visceral leishmaniasis: A review

21 January 2018

1 reference

Immune response to leishmania: paradox rather than paradigm

21 January 2018

1 reference

SIR2-deficient Leishmania infantum induces a defined IFN-gamma/IL-10 pattern that correlates with protection

21 January 2018

1 reference

Live vaccination tactics: possible approaches for controlling visceral leishmaniasis

21 January 2018

1 reference

Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae

21 January 2018

1 reference

Exploiting Leishmania tarentolae cell-free extracts for the synthesis of human solute carriers

21 January 2018

1 reference

Expression of a truncated hepatitis E virus capsid protein in the protozoan organism Leishmania tarentolae and its application in a serological assay.

21 January 2018

1 reference

Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis

21 January 2018

1 reference

A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection

21 January 2018

1 reference

Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability

21 January 2018

1 reference

CD4 CD25 regulatory T cells control Leishmania major persistence and immunity

21 January 2018

1 reference

Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

21 January 2018

1 reference

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

21 January 2018

1 reference

Vector transmission of leishmania abrogates vaccine-induced protective immunity

21 January 2018

1 reference

Live attenuated Leishmania vaccines: a potential strategic alternative

21 January 2018

1 reference

Myd88-dependent in vivo maturation of splenic dendritic cells induced by Leishmania donovani and other Leishmania species

21 January 2018

1 reference

Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major

21 January 2018

1 reference

Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation

21 January 2018

1 reference

Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice

21 January 2018

1 reference

Development of a safe live Leishmania vaccine line by gene replacement.

21 January 2018

1 reference

Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination

21 January 2018

1 reference

Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response

21 January 2018

1 reference

Tools and approaches to ensure quality of vaccines throughout the cold chain

21 January 2018

1 reference

Recombinant Leishmania major lipophosphoglycan 3 activates human T-lymphocytes via TLR2-independent pathway

21 January 2018

1 reference

Immune response in susceptible BALB/c mice immunized with DNA encoding Lipophosphoglycan 3 of Leishmania infantum

21 January 2018

1 reference

TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.

21 January 2018

1 reference

Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine

21 January 2018

1 reference

Splenic accumulation of IL-10 mRNA in T cells distinct from CD4 CD25 (Foxp3) regulatory T cells in human visceral leishmaniasis

21 January 2018

1 reference

Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

21 January 2018

1 reference

Leishmania vaccines: progress and problems.

21 January 2018

1 reference

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

21 January 2018

1 reference

The magnitude of CD4 T‐cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice

21 January 2018

1 reference

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

21 January 2018

1 reference

Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis

21 January 2018

1 reference

Retracted: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis

21 January 2018

1 reference

Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen

21 January 2018

1 reference

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/SJI.12557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28426153 AND SRC:MED&resulttype=core&format=json

18 March 2020

1 reference